Last reviewed · How we verify

Bupivacaine HCl Treatment 1c

Durect · Phase 2 active Small molecule

Bupivacaine HCl Treatment 1c is a Local anesthetic Small molecule drug developed by Durect. It is currently in Phase 2 development for Local anesthesia for surgical procedures, Pain management for postoperative pain.

Bupivacaine HCl is a local anesthetic that works by blocking sodium channels in nerve fibers to prevent the initiation and transmission of nerve impulses.

Bupivacaine HCl is a local anesthetic that works by blocking sodium channels in nerve fibers to prevent the initiation and transmission of nerve impulses. Used for Local anesthesia for surgical procedures, Pain management for postoperative pain.

At a glance

Generic nameBupivacaine HCl Treatment 1c
SponsorDurect
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 2

Mechanism of action

This results in a temporary loss of sensation and motor function in the affected area. Bupivacaine HCl is a hydrochloride salt of bupivacaine, a synthetic amide local anesthetic. It is used for regional anesthesia and pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bupivacaine HCl Treatment 1c

What is Bupivacaine HCl Treatment 1c?

Bupivacaine HCl Treatment 1c is a Local anesthetic drug developed by Durect, indicated for Local anesthesia for surgical procedures, Pain management for postoperative pain.

How does Bupivacaine HCl Treatment 1c work?

Bupivacaine HCl is a local anesthetic that works by blocking sodium channels in nerve fibers to prevent the initiation and transmission of nerve impulses.

What is Bupivacaine HCl Treatment 1c used for?

Bupivacaine HCl Treatment 1c is indicated for Local anesthesia for surgical procedures, Pain management for postoperative pain.

Who makes Bupivacaine HCl Treatment 1c?

Bupivacaine HCl Treatment 1c is developed by Durect (see full Durect pipeline at /company/durect).

What drug class is Bupivacaine HCl Treatment 1c in?

Bupivacaine HCl Treatment 1c belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Bupivacaine HCl Treatment 1c in?

Bupivacaine HCl Treatment 1c is in Phase 2.

What are the side effects of Bupivacaine HCl Treatment 1c?

Common side effects of Bupivacaine HCl Treatment 1c include Central nervous system depression, Cardiovascular effects, Nausea and vomiting.

What does Bupivacaine HCl Treatment 1c target?

Bupivacaine HCl Treatment 1c targets Voltage-gated sodium channels and is a Local anesthetic.

Related